Smith, B. D., Lachowiez, C. A., Ambinder, A. J., Binder, G., Angiolillo, A., Potluri, R., … LeBlanc, T. W. (2024). Waiting for Mutational Test Results Does Not Delay Time to Treatment for Newly Diagnosed AML Ineligible for Intensive Chemo. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 24, pp. S331–S331).

Smith, B Douglas, Curtis A. Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Ravi Potluri, Eros Papademetriou, and Thomas W. LeBlanc. “Waiting for Mutational Test Results Does Not Delay Time to Treatment for Newly Diagnosed AML Ineligible for Intensive Chemo.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 24:S331–S331, 2024.

Smith BD, Lachowiez CA, Ambinder AJ, Binder G, Angiolillo A, Potluri R, et al. Waiting for Mutational Test Results Does Not Delay Time to Treatment for Newly Diagnosed AML Ineligible for Intensive Chemo. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S331–S331.

Smith, B. Douglas, et al. “Waiting for Mutational Test Results Does Not Delay Time to Treatment for Newly Diagnosed AML Ineligible for Intensive Chemo.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 24, 2024, pp. S331–S331.

Smith BD, Lachowiez CA, Ambinder AJ, Binder G, Angiolillo A, Potluri R, Papademetriou E, LeBlanc TW. Waiting for Mutational Test Results Does Not Delay Time to Treatment for Newly Diagnosed AML Ineligible for Intensive Chemo. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S331–S331.